Suki
Suki, founded in 2020 in California, USA, develops AI-powered voice assistants that help physicians handle tasks such as medical documentation and clinical notes.
Position in SVTR
Snapshot 2026-10-20- Startup SignalsTop 50%↓17
- Life SciencesTop 25%–
- Healthcare ServicesTop 50%–
- AudioTop 25%↓1
- AssistantTop 50%↓2
About
Suki, founded in 2020 in California, USA, develops AI-powered voice assistants that help physicians handle tasks such as medical documentation and clinical notes. The company has partnered with over 300 healthcare systems and integrates with Epic, Oracle's Cerner, Athena, and MEDITECH.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / core team
Investors
Funding history
- 2026-10-13Series D+$90M
Investors · Healthier Capital、Crosslink Capital、Hercules Capital、Venrock、Flare Capital Partners、Hedosophia、Philips Ventures、Zoom Ventures
- 2024-10$70M
Investors · Hedosophia、Venrock、March Capital
Source · SVTR Weekly #074
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Suki
Suki, founded in 2020 in California, USA, develops AI-powered voice assistants that help physicians handle tasks such as medical documentation and clinical notes. The company has partnered with over 300 healthcare systems and integrates with Epic, Oracle's Cerner, Athena, and MEDITECH.
Series D+ · $250M · 2026-10
$250M
United States
BusinessLatest roundTotal raisedDate- Commure
Commure, founded in 2017 in Mountain View, California, USA, offers healthcare organizations an AI platform for administrative tasks, revenue cycle management, clinical documentation, coding, scheduling, and operational workflows.
$750M · 2026-05
$750M - Forus
Forus (formerly Tandem), founded in 2023 in New York, uses AI to automate prescription management, insurance verification, prior authorization, appeals, and pharmacy routing workflows.
Series C · $300M · 2026-09 · Valuation $3.0B
$300MValuation $3.0B - Assort Health
Assort Health, founded in 2023 in San Francisco, provides a voice AI agent platform for healthcare organizations that automates appointment scheduling, triage, referrals, documentation, and payment processing.
Series C · $222M · 2026-06 · Valuation $1.2B
$222MValuation $1.2B
Europe
BusinessLatest roundTotal raisedDate- Tandem Health
Tandem Health, founded in 2023 in Sweden, develops AI-powered software that helps healthcare providers by automatically generating medical records. The platform leverages GPT-4 and OpenAI's Whisper speech recognition technology, with adaptations for Swedish medical terminology.
Series B · $160M · 2026-09
$160M - Voize
Voize, founded in 2020 in Potsdam, Germany, provides an AI-powered mobile app that enables care workers to document patient information via voice input, automatically generating structured reports.
Series A · $59M · 2025-11
$59M - Vocca
Vocca, founded in 2024 in Paris with an office in New York, builds specialty-specific AI voice agents for medical practices that pair natural-language models with clinical scheduling rules to answer patient calls and book, reschedule or cancel appointments directly in existing practice-management and EHR systems, plus reminders, exam prep and patient reactivation. It serves 1,500+ practices across 20+ specialties in the US and Europe, handling over a million calls a month with about 70% resolved without staff.
Series A · $25M · 2026-10
$25M
Other / unspecified
BusinessLatest roundTotal raisedDate- Heidi Health
Heidi Health (formerly Oscer), founded in 2019 in Melbourne, Australia, reduces administrative burden on physicians by using AI to convert consultation recordings into medical histories, referral letters, billing forms, and other clinical documents.
Series C · $437M · 2026-09 · Valuation $900M
$437MValuation $900M - Craif
Craif, founded in 2018 in Tokyo, detects cancer at early stages using urine-based microRNA biomarkers and AI.
Series D+ · $88M · 2026-08
$88M - Even Healthcare
Even Healthcare is a Bengaluru-based managed care company offering subscription memberships that integrate primary and secondary care through owned clinics, its own hospitals and partner facilities, coordinating preventive care with insurers to shift incentives from fee-for-service volume to patient outcomes.
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
39 Life Sciences deals in the last 24 months · 7 at a nearby stage · 35 in California
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 3 at a nearby stage · 31 in California
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 10 at a nearby stage · 22 in California
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 6 at a nearby stage · 20 in California
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 8 at a nearby stage · 15 in California
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 5 at a nearby stage · 14 in California
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.